• Others
The subcutaneous ICD (S-ICD) is inserted without placing the leads into the heart. The device is
inserted below the left axilla, or armpit in line with the rib cage. The lead connected to the
device is laired under the skin more willingly than inside the heart. Some of the advantages of
the S-ICD are the lack of immediate or long-term complications caused by inserting a lead into
the heart, such as collapse of the lung and perforation of the heart. Subcutaneous implantable
cardioverter defibrillators are the main driver for the global ICD market due to the
aforementioned reasons. The rise in adoption of S-ICDs will propel the overall implantable
cardioverter-defibrillators market in the forecast period.
Inquire Here Before Purchase of Research Report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/223
Some of the key players operating in the global implantable cardioverter-defibrillators market
are Imricor Medical Systems, Boston Scientific Corporation, Inc., LivaNova PLC Company,
MicroPort Scientific Corporation, Mayo Clinic US, Medtronic plc, St. Jude Medical, Inc., and
MRI Interventions, Inc.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com